KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Return on Capital Employed (2018 - 2025)

ClearPoint Neuro's Return on Capital Employed history spans 12 years, with the latest figure at 0.43% for Q3 2025.

  • For Q3 2025, Return on Capital Employed rose 6.0% year-over-year to 0.43%; the TTM value through Sep 2025 reached 0.43%, up 6.0%, while the annual FY2024 figure was 0.65%, 11.0% down from the prior year.
  • Return on Capital Employed for Q3 2025 was 0.43% at ClearPoint Neuro, up from 0.58% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.13% in Q2 2021 and bottomed at 0.78% in Q1 2025.
  • The 5-year median for Return on Capital Employed is 0.43% (2025), against an average of 0.42%.
  • The largest annual shift saw Return on Capital Employed rose 19bps in 2021 before it dropped -30bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 0.21% in 2021, then tumbled by -53bps to 0.33% in 2022, then plummeted by -91bps to 0.63% in 2023, then dropped by -7bps to 0.67% in 2024, then surged by 37bps to 0.43% in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Return on Capital Employed are 0.43% (Q3 2025), 0.58% (Q2 2025), and 0.78% (Q1 2025).